MENLO PARK, Calif.--(BUSINESS WIRE)--CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, will release its 2015 fourth quarter financial results on Wednesday, March 9, 2016, and will host a call for shareholders the same day at 2:00 p.m. (PST).
